SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001214659-24-007591
Filing Date
2024-04-26
Accepted
2024-04-26 08:45:32
Documents
3
Period of Report
2024-04-26

Document Format Files

Seq Description Document Type Size
1 s4252406k.htm 6-K 16675
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 321642
3 EXHIBIT 99.1 ex99_1.htm EX-99.1 31620
  Complete submission text file 0001214659-24-007591.txt   371107
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37652 | Film No.: 24879046
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)